title: Prolongation of allograft survival in ccr7-deficient mice.
abstract: BACKGROUND
  Lymphocyte homing to secondary lymphoid organs is thought to be required for initiation of the alloreactive immune response. Because CCR7 is the essential chemokine receptor responsible for lymphocyte and dendritic cell homing to secondary lymphoid organs, allograft survival was analyzed in CCR7-deficient (CCR7) mice.
  
  
  METHODS
  Heterotopic heart and skin allotransplantation was performed in CCR7 and wild-type (WT) recipients. Graft survival was monitored daily. Grafts and draining lymph nodes were analyzed by immunohistology and flow cytometry at different time points. Groups of mice were splenectomized at the day of allotransplantation.
  
  
  RESULTS
  A significant though modest prolongation of allograft survival in CCR7 recipients was observed for heart grafts (WT, 7.3 +/- 0.5 days; CCR7, 10.7 +/- 2.8 days) and skin grafts (WT, 8.9 +/- 0.9 days; CCR7, 12.3 +/- 0.9 days). This was accompanied by a delay in the cellular infiltration of allografts. T-cell accumulation and expansion in the draining lymph nodes in CCR7 recipients was severely impaired. Splenectomy had only a moderate prolongation effect on allograft survival in CCR7 mice.
  
  
  CONCLUSIONS
  These results suggest that CCR7-dependent processes support allograft rejection yet are dispensable for the rejection response.
authors.affiliation: Department of Visceral and Transplantation Surgery, Hannover Medical School, 30625 Hannover, Germany.
authors.forename: Jan H
authors.initials: JH
authors.lastname: Beckmann
authors.forename: Sheng
authors.initials: S
authors.lastname: Yan
authors.forename: Heike
authors.initials: H
authors.lastname: Lührs
authors.forename: Bettina
authors.initials: B
authors.lastname: Heid
authors.forename: Susanne
authors.initials: S
authors.lastname: Skubich
authors.forename: Reinhold
authors.initials: R
authors.lastname: Förster
authors.forename: Matthias W
authors.initials: MW
authors.lastname: Hoffmann
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D005434:Flow Cytometry / Q000379:methods; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D006720:Homozygote; D018655:Lymphocyte Count; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D054400:Receptors, CCR7; D019707:Receptors, Chemokine / Q000172:deficiency* / Q000235:genetics / Q000502:physiology*; D016038:Skin Transplantation / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology*
chemical_list: C515371:Ccr7 protein, mouse; D054400:Receptors, CCR7; D019707:Receptors, Chemokine